Chemical Name | Chemical Identifier | Evidence |
---|---|---|
Amyl nitrite | CID:10026 | Clinical observation |
Masitinib | CID:10074640 | Clinical observation |
Sepantronium | CID:10126189 | Samples verified |
Undecylenoyl phenylalanine | CID:10308702 | Samples verified |
Cyfluthrin | CID:104926 | Samples verified |
Perchlorate | CID:123351 | Retrospective study |
Gefitinib | CID:123631 | Clinical observation |
Paraquat | CID:15939 | Clinical observation |
Stavudine | CID:18283 | Clinical observation |
Clofazimine | CID:2794 | Clinical observation |
Clonidine | CID:2803 | Clinical observation |
Cypermethrin | CID:2912 | Samples verified |
Thiopental | CID:3000715 | Clinical observation |
Clofenotane | CID:3036 | Retrospective study |
Dasatinib | CID:3062316 | Clinical observation |
Triamcinolone | CID:31307 | Clinical observation |
Fentanyl | CID:3345 | Clinical observation |
Zidovudine | CID:35370 | Samples verified |
3,3',4,4',5,5'-Hexachlorobiphenyl | CID:36231 | Retrospective study |
Methylphenidate | CID:4158 | Samples verified; Clinical observation; Cohort study |
Minoxidil | CID:4201 | Samples verified |
Mitoxantrone | CID:4212 | Clinical observation |
Vemurafenib | CID:42611257 | Samples verified |
Nevirapine | CID:4463 | Clinical observation |
Ribociclib | CID:44631912 | Samples verified; Clinical observation |
Abemaciclib | CID:46220502 | Samples verified |
Coenzyme Q10 | CID:5281915 | Samples verified |
Isotretinoin | CID:5282379 | Samples verified; Clinical observation |
Imatinib | CID:5291 | Samples verified; Clinical observation; Cohort study |
Latanoprost | CID:5311221 | Clinical observation |
Palbociclib | CID:5330286 | Samples verified |
Arsenic | CID:5359596 | Clinical observation |
Tazarotene | CID:5381 | Clinical observation |
Piroxicam | CID:54676228 | Clinical observation |
Atomoxetine | CID:54841 | Clinical observation |
Tranexamic acid | CID:5526 | Clinical observation |
Imiquimod | CID:57469 | Samples verified; Clinical observation; Retrospective study |
Rotigotine | CID:59227 | Clinical observation |
Testosterone | CID:6013 | Samples verified |
Lamivudine | CID:60825 | Clinical observation |
Capecitabine | CID:60953 | Clinical observation |
Psoralen | CID:6199 | Samples verified |
Triamcinolone diacetate | CID:6216 | Clinical observation |
Triamcinolone Acetonide | CID:6436 | Clinical observation |
Dimethyl Sulfate | CID:6497 | Samples verified |
Diphenylcyclopropenone | CID:65057 | Samples verified; Clinical observation |
3,4-Dibutoxy-3-cyclobutene-1,2-dione | CID:65108 | Clinical observation |
Bisphenol A | CID:6623 | Retrospective study |
Methylprednisolone | CID:6741 | Clinical observation |
Kojic dipalmitate | CID:71587292 | Clinical observation |
Hexachlorobenzene | CID:8370 | Retrospective study |
Nicotinamide | CID:936 | Samples verified |
4-(3-Hydroxybutyl)phenol | CID:97790 | Samples verified |
ViCEKb is a knowledgebase of chemicals linked with pathogenesis of vitiligo in humans that have been curated from various published case study reports, clinical observation reports and research articles. The authors are not liable for any inaccuracies or omissions of any chemicals or published scientific literature pertaining to vitiligo-triggering chemicals in this resource. Users are advised to exercise their own discretion while judging the weight of evidence for vitiligo-triggering chemicals compiled in this resource. Importantly, our sole goal to build this resource on potential vitiligo-triggering chemicals is to enable future basic research on this topic, and it does not necessarily reflect the views or objectives of our employers or funders.